Re: Thomas Powles, Zoe June Assaf, Viraj Degaonkar, et al. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma. Eur Urol 2024;85:114-22.
| Autor: | Beccia V; Università Cattolica del Sacro Cuore, Rome, Italy., Pinterpe G; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Iacovelli R; Università Cattolica del Sacro Cuore, Rome, Italy; Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Electronic address: roberto.iacovelli@policlinicogemelli.it. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | European urology [Eur Urol] 2024 Aug; Vol. 86 (2), pp. e44-e45. Date of Electronic Publication: 2024 Apr 21. |
| DOI: | 10.1016/j.eururo.2024.03.040 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect